Brigitte Robertson, MD, shares information on innovative, genetically targeted treatments for alcohol use disorder, aiming to personalize care and improve patient outcomes.
Brigitte Robertson, MD
Advertisement
Dr Robertson is the chief medical officer at Adial Pharmaceuticals.
Articles by Brigitte Robertson, MD
Advertisement
Latest Updated Articles
Combating Misconceptions About Alcohol Use Disorder: In Conversation With Brigitte Robertson, MDPublished: May 13th 2025 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive FDA Meeting for Abuse Deterrent Fentanyl Patch
2
Positive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD
3
“Porosity”: Connecting 2 Western Cultural Psychiatric Discourses in Tokyo by Way of Naples
4
Candy and Other Food Treats or Tricks
5
